These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29796911)

  • 21. Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease.
    Shi Y; Li J; Cai S; Zhao H; Zhao H; Sun G; Yang Y
    Front Cell Infect Microbiol; 2023; 13():1205348. PubMed ID: 37662013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
    Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
    Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of proton pump inhibitors and other commonly used medication on the gut microbiota.
    Imhann F; Vich Vila A; Bonder MJ; Lopez Manosalva AG; Koonen DPY; Fu J; Wijmenga C; Zhernakova A; Weersma RK
    Gut Microbes; 2017 Jul; 8(4):351-358. PubMed ID: 28118083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study.
    Takagi T; Naito Y; Inoue R; Kashiwagi S; Uchiyama K; Mizushima K; Tsuchiya S; Okayama T; Dohi O; Yoshida N; Kamada K; Ishikawa T; Handa O; Konishi H; Okuda K; Tsujimoto Y; Ohnogi H; Itoh Y
    J Clin Biochem Nutr; 2018 Jan; 62(1):100-105. PubMed ID: 29371761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duodenal Dysbiosis and Relation to the Efficacy of Proton Pump Inhibitors in Functional Dyspepsia.
    Wauters L; Tito RY; Ceulemans M; Lambaerts M; Accarie A; Rymenans L; Verspecht C; Toth J; Mols R; Augustijns P; Tack J; Vanuytsel T; Raes J
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiota and butyrate level changes associated with the long-term administration of proton pump inhibitors to old rats.
    Lee SM; Kim N; Nam RH; Park JH; Choi SI; Park YT; Kim YR; Seok YJ; Shin CM; Lee DH
    Sci Rep; 2019 Apr; 9(1):6626. PubMed ID: 31036935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of the effects of proton pump inhibitors on the human gut microbiota.
    Zhang J; Zhang C; Zhang Q; Yu L; Chen W; Xue Y; Zhai Q
    BMC Microbiol; 2023 Jun; 23(1):171. PubMed ID: 37337143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Celiac disease serology and gut microbiome following proton pump inhibitor treatment.
    Jang S; Lebwohl B; Abrams JA; Green PHR; Freedberg DE; Alaedini A
    Medicine (Baltimore); 2020 Aug; 99(35):e21488. PubMed ID: 32871870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut Microbiota Characteristics in Children After the Use of Proton Pump Inhibitors.
    Simakachorn L; Tanpowpong P; Chanprasertyothin S; Thongpradit S; Treepongkaruna S
    Turk J Gastroenterol; 2021 Jan; 32(1):70-75. PubMed ID: 33893768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study.
    Pyo JH; Kim TJ; Lee H; Choi SC; Cho SJ; Choi YH; Min YW; Min BH; Lee JH; Kang M; Lee YC; Kim JJ
    J Gastroenterol Hepatol; 2021 May; 36(5):1235-1243. PubMed ID: 32886822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
    Singh A; Cresci GA; Kirby DF
    Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes.
    Sato J; Kanazawa A; Ikeda F; Yoshihara T; Goto H; Abe H; Komiya K; Kawaguchi M; Shimizu T; Ogihara T; Tamura Y; Sakurai Y; Yamamoto R; Mita T; Fujitani Y; Fukuda H; Nomoto K; Takahashi T; Asahara T; Hirose T; Nagata S; Yamashiro Y; Watada H
    Diabetes Care; 2014 Aug; 37(8):2343-50. PubMed ID: 24824547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats.
    Yang YSH; Chang HW; Lin IH; Chien LN; Wu MJ; Liu YR; Chu PG; Xie G; Dong F; Jia W; Chang VHS; Yen Y
    Sci Rep; 2020 Jan; 10(1):866. PubMed ID: 31964941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia.
    Gommers LMM; Ederveen THA; van der Wijst J; Overmars-Bos C; Kortman GAM; Boekhorst J; Bindels RJM; de Baaij JHF; Hoenderop JGJ
    FASEB J; 2019 Oct; 33(10):11235-11246. PubMed ID: 31299175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes.
    Weitsman S; Celly S; Leite G; Mathur R; Sedighi R; Barlow GM; Morales W; Sanchez M; Parodi G; Villanueva-Millan MJ; Rezaie A; Pimentel M
    Dig Dis Sci; 2022 Jan; 67(1):224-232. PubMed ID: 33534012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal Microbiome Changes in Children Exposed to Proton Pump Inhibitors.
    Zhang YJ; Connearney S; Hester L; Du M; Catacora A; Akkara A; Wen A; Bry L; Alm EJ; Rosen R
    Clin Transl Gastroenterol; 2024 Sep; 15(9):e1. PubMed ID: 38624107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications.
    Le Bastard Q; Al-Ghalith GA; Grégoire M; Chapelet G; Javaudin F; Dailly E; Batard E; Knights D; Montassier E
    Aliment Pharmacol Ther; 2018 Feb; 47(3):332-345. PubMed ID: 29205415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab.
    Hopkins AM; Kichenadasse G; Karapetis CS; Rowland A; Sorich MJ
    Clin Cancer Res; 2020 Oct; 26(20):5487-5493. PubMed ID: 32933995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke.
    Yamashiro K; Tanaka R; Urabe T; Ueno Y; Yamashiro Y; Nomoto K; Takahashi T; Tsuji H; Asahara T; Hattori N
    PLoS One; 2017; 12(2):e0171521. PubMed ID: 28166278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of gastric acid suppression on probiotic colonization in a double blinded randomized clinical trial.
    Singh G; Haileselassie Y; Briscoe L; Bai L; Patel A; Sanjines E; Hendler S; Singh PK; Garud NR; Limketkai BN; Habtezion A
    Clin Nutr ESPEN; 2022 Feb; 47():70-77. PubMed ID: 35063245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.